4//SEC Filing
FRAGIN GARY S 4
Accession 0001179110-10-006264
CIK 0001107421other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:27 PM ET
Size
16.6 KB
Accession
0001179110-10-006264
Insider Transaction Report
Form 4
FRAGIN GARY S
Director
Transactions
- Award
Stock Option (right to buy)
2010-03-31+15,000→ 15,000 totalExercise: $5.09From: 2011-03-31Exp: 2020-03-31→ Common Stock, $.001 par value (15,000 underlying) - Award
Common Stock, $.001 par value
2010-03-31+15,000→ 67,500 total
Holdings
- 7,500
Stock Option (right to buy)
Exercise: $2.85Exp: 2019-12-31→ Common Stock, $.001 par value (7,500 underlying) - 15,000
Stock Option (right to buy)
Exercise: $4.85Exp: 2017-06-18→ Common Stock (15,000 underlying) - 15,000
Director Stock Option (right to buy)
Exercise: $5.01From: 2006-04-26Exp: 2016-04-26→ Common Stock (15,000 underlying) - 20,000
Stock Option (right to buy)
Exercise: $2.73Exp: 2017-12-12→ Common Stock (20,000 underlying) - 15,029
Director Stock Option (right to buy)
Exercise: $4.31From: 2006-12-22Exp: 2014-12-22→ Common Stock, $.001 par value (15,029 underlying)
Footnotes (6)
- [F1]Grant of restricted stock; restrictions lapse on the anniversary of the date of grant.
- [F2]In addition to the current grant, includes a prior grant of restricted stock with restrictions that will lapse as to 3,750 shares on each of December 31, 2010 and December 31, 2011.
- [F3]5,000 shares vest on each of 6/18/08, 6/18/09 and 6/18/10.
- [F4]6,667 shares vest on each of 12/12/08 and 12/12/09; 6,666 shares vest on 12/12/10.
- [F5]5,000 shares vest on each of 12/31/2009, 6/30/2010 and 12/31/2010.
- [F6]3,750 shares vest on each of 12/31/2010 and 12/31/2011.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001338534
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 4:27 PM ET
- Size
- 16.6 KB